Vaccines based on protein fragments unique to the scar-forming cells that drive idiopathic pulmonary fibrosis (IPF) significantly reduced lung scarring in both mouse models and human cell experiments, according to a study. While the vaccine approach showed promise in mice, advancing it to clinical trials will require patient selection…
Discussion
Are you familiar with the phrase “one size fits all?” When you see it, how do you react? For me, unless it’s on a baseball cap with an adjustable strap, I’m skeptical. But I’m not always a skeptic. When I was diagnosed with idiopathic pulmonary fibrosis (IPF) in…
A regulatory committee of the European Medicines Agency is urging approval of the oral therapy Jascayd (nerandomilast) in the European Union for treating adults with idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF), two forms of the respiratory disease. While the European Commission — which makes all final…
Becoming educated and informed about PF is a good first step. Here you’ll find general information about the disease, including diagnosis, symptoms, and causes.
It helps to know others have been where you are now. Here’s a collection of our columnists’ words of wisdom to help you along on your PF journey.
There is no cure for PF yet, but here you can find more information about current therapeutic approaches, as well as experimental treatments that are in the pipeline.
Get regular updates to your inbox.
